212 related articles for article (PubMed ID: 6091965)
1. Dopamine agonists and Parkinson's disease.
Burton K; Calne DB
Clin Neurol Neurosurg; 1984; 86(3):172-7. PubMed ID: 6091965
[TBL] [Abstract][Full Text] [Related]
2. Dopamine agonists as primary treatment in Parkinson's disease.
Rinne UK
Adv Neurol; 1987; 45():519-23. PubMed ID: 3103394
[No Abstract] [Full Text] [Related]
3. DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
Mov Disord; 2002; 17 Suppl 4():S53-67. PubMed ID: 12211141
[No Abstract] [Full Text] [Related]
4. [Use of dopamine agonists in the treatment of Parkinson's disease].
Gekht AB
Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):54-8. PubMed ID: 12378886
[No Abstract] [Full Text] [Related]
5. Dopamine agonists in Parkinson's disease.
Calne DB; Burton K; Beckman J; Martin WR
Can J Neurol Sci; 1984 Feb; 11(1 Suppl):221-4. PubMed ID: 6231979
[TBL] [Abstract][Full Text] [Related]
6. [Dopamine agonists in the therapy of parkinson syndrome].
Kapfhammer HP; RĂ¼ther E
Nervenarzt; 1985 Feb; 56(2):69-81. PubMed ID: 3982566
[No Abstract] [Full Text] [Related]
7. Clinical pharmacology of dopamine agonists in Parkinson's disease.
Lange KW
Drugs Aging; 1998 Nov; 13(5):381-9. PubMed ID: 9829165
[TBL] [Abstract][Full Text] [Related]
8. Sleep attacks and Parkinson's disease treatment.
Ferreira JJ; Galitzky M; Montastruc JL; Rascol O
Lancet; 2000 Apr; 355(9212):1333-4. PubMed ID: 10776750
[TBL] [Abstract][Full Text] [Related]
9. Current status of dopamine agonists in Parkinson's disease management.
Montastruc JL; Rascol O; Senard JM
Drugs; 1993 Sep; 46(3):384-393. PubMed ID: 7693430
[TBL] [Abstract][Full Text] [Related]
10. [Dopaminergic agonists in Parkinson disease].
Dubois B; Agid Y
Rev Prat; 1986 Jan; 36(5):207-14. PubMed ID: 3961400
[No Abstract] [Full Text] [Related]
11. Dopamine receptor stimulating agonists in the treatment of Parkinson's disease.
Agid Y; Barroche G; Bonnet AM; Javoy-Agid F; Kato G; Lhermitte F; Pollak P; Signoret JL
Biomedicine; 1979 Jun; 30(2):67-71. PubMed ID: 383169
[TBL] [Abstract][Full Text] [Related]
12. Pergolide and lisuride in advanced Parkinson's disease.
Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Goldstein M
Adv Neurol; 1984; 40():503-7. PubMed ID: 6695627
[TBL] [Abstract][Full Text] [Related]
13. Update on dopamine agonists in Parkinson's disease: "beyond bromocriptine".
Lang AE
Can J Neurol Sci; 1987 Aug; 14(3 Suppl):474-82. PubMed ID: 3315148
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Goetz CG; Poewe W; Rascol O; Sampaio C
Mov Disord; 2005 May; 20(5):523-39. PubMed ID: 15818599
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic agonists in the treatment of Parkinson's disease.
Goetz CG; Diederich NJ
Neurol Clin; 1992 May; 10(2):527-40. PubMed ID: 1350052
[TBL] [Abstract][Full Text] [Related]
16. [Optimization of the treatment of Parkinson's disease using dopamine agonists].
Rinne UK
Arch Neurobiol (Madr); 1991; 54(6):282-7. PubMed ID: 1687430
[No Abstract] [Full Text] [Related]
17. Use of apomorphine in Parkinson's disease.
Stocchi F
Neurol Sci; 2008 Dec; 29 Suppl 5():S383-6. PubMed ID: 19381769
[TBL] [Abstract][Full Text] [Related]
18. Levodopa in the treatment of Parkinson's disease: current controversies.
Gerlach M; Reichmann H; Riederer P
Mov Disord; 2005 May; 20(5):643; author reply 643-4. PubMed ID: 15732130
[No Abstract] [Full Text] [Related]
19. Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
Goetz CG; Tanner CM; Glantz RH; Klawans HL
Neurology; 1985 May; 35(5):749-51. PubMed ID: 3990974
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
Schneider E; Hubener K; Fischer PA
Neurology; 1983 Apr; 33(4):468-72. PubMed ID: 6682193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]